• Wed, November 9, 2022

by: WOPRAI

Rudy Kessinger Maintained (AKAM) at Strong Buy with Decreased Target to $100 on, Nov 9th, 2022

by: WOPRAI

Amit Daryanani Maintained (AKAM) at Buy with Decreased Target to $105 on, Nov 9th, 2022

by: WOPRAI

Mark Murphy Maintained (AKAM) at Sell with Decreased Target to $73 on, Nov 9th, 2022

by: WOPRAI

James Fish Maintained (AKAM) at Hold with Decreased Target to $93 on, Nov 9th, 2022

by: WOPRAI

Ambrish Srivastava Maintained (AIP) at Hold with Decreased Target to $7 on, Nov 9th, 2022

by: WOPRAI

Jerry Revich Maintained (CAT) at Strong Buy with Increased Target to $273 on, Nov 9th, 2022

by: WOPRAI

Chris Pierce Maintained (CARG) at Strong Buy with Decreased Target to $16 on, Nov 9th, 2022

by: WOPRAI

Aaron Kessler Maintained (CARG) at Buy with Decreased Target to $16 on, Nov 9th, 2022

by: WOPRAI

Brad Erickson Maintained (CARG) at Buy with Decreased Target to $19 on, Nov 9th, 2022

by: WOPRAI

Tom White Maintained (CARG) at Hold with Decreased Target to $12 on, Nov 9th, 2022

by: WOPRAI

Robbie Marcus Downgraded (BVS) to Sell on, Nov 9th, 2022

by: WOPRAI

Kyle Rose Downgraded (BVS) to Hold on, Nov 9th, 2022

by: WOPRAI

Blair Abernethy Maintained (BSY) at Strong Buy with Increased Target to $39 on, Nov 9th, 2022

by: WOPRAI

Matthew Broome Maintained (BSY) at Strong Buy with Increased Target to $40 on, Nov 9th, 2022

by: WOPRAI

Joshua Reilly Maintained (AXON) at Strong Buy with Increased Target to $200 on, Nov 9th, 2022

by: WOPRAI

Sami Badri Maintained (AXON) at Buy with Increased Target to $152 on, Nov 9th, 2022

by: WOPRAI

Meta Marshall Maintained (AXON) at Hold with Increased Target to $130 on, Nov 9th, 2022

by: WOPRAI

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $80 on, Nov 9th, 2022

by: WOPRAI

Mario Pierry Downgraded (BBD) to Hold on, Nov 9th, 2022

by: WOPRAI

Mario Pierry Downgraded (BBDO) to Hold on, Nov 9th, 2022

by: WOPRAI

Swayampakula Ramakanth Maintained (ALXO) at Strong Buy with Decreased Target to $65 on, Nov 9th, 2022

by: WOPRAI

Adam Tindle Maintained (ALRM) at Strong Buy with Decreased Target to $65 on, Nov 9th, 2022

by: WOPRAI

Saket Kalia Maintained (ALRM) at Hold with Decreased Target to $52 on, Nov 9th, 2022

by: WOPRAI

Dana Telsey Maintained (BIRD) at Buy with Decreased Target to $100 on, Nov 9th, 2022

by: WOPRAI

Mark Altschwager Maintained (BIRD) at Buy with Decreased Target to $140 on, Nov 9th, 2022

by: WOPRAI

Steven Chercover Downgraded (BLDR) to Hold and Held Target at $68 on, Nov 9th, 2022

by: WOPRAI

Mike Dahl Maintained (BLDR) at Hold with Decreased Target to $74 on, Nov 9th, 2022

by: WOPRAI

Ketan Mamtora Maintained (BLDR) at Buy with Decreased Target to $80 on, Nov 9th, 2022

by: WOPRAI

Trey Grooms Maintained (BLDR) at Buy with Decreased Target to $80 on, Nov 9th, 2022

by: WOPRAI

Duffy Fischer Maintained (APD) at Strong Buy with Increased Target to $325 on, Nov 9th, 2022

by: WOPRAI

PJ Juvekar Maintained (APD) at Hold with Increased Target to $294 on, Nov 9th, 2022

by: WOPRAI

Michael Petusky Upgraded (ANIK) to Buy and Held Target at $31 on, Nov 9th, 2022

by: WOPRAI

Donald Fandetti Maintained (AOMR) at Buy with Decreased Target to $10 on, Nov 9th, 2022

by: WOPRAI

Steven Seedhouse Maintained (ANAB) at Buy with Increased Target to $38 on, Nov 9th, 2022

by: WOPRAI

Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $58 on, Nov 9th, 2022

by: WOPRAI

James Fish Maintained (ZM) at Hold with Decreased Target to $84 on, Nov 9th, 2022

by: WOPRAI

Adam Tindle Maintained (ARLO) at Buy with Decreased Target to $11 on, Nov 9th, 2022

by: WOPRAI

Hamed Khorsand Maintained (ARLO) at Strong Buy with Decreased Target to $8 on, Nov 9th, 2022

by: WOPRAI

Ravi Shanker Maintained (ARCB) at Buy with Decreased Target to $139 on, Nov 9th, 2022

by: WOPRAI

Chad Beynon Maintained (ACEL) at Buy with Decreased Target to $13 on, Nov 9th, 2022

by: WOPRAI

Puneet Souda Maintained (ABCL) at Buy with Increased Target to $20 on, Nov 9th, 2022

by: WOPRAI

Arvind Ramnani Maintained (AEVA) at Hold with Decreased Target to $11 on, Nov 9th, 2022

by: WOPRAI

Joseph Moore Maintained (AEVA) at Hold with Decreased Target to $13 on, Nov 9th, 2022

by: WOPRAI

Ryan Levine Maintained (AES) at Strong Buy with Increased Target to $30 on, Nov 9th, 2022

by: WOPRAI

Tazeen Ahmad Downgraded (ADCT) to Hold and Decreased Target to $7 on, Nov 9th, 2022

by: WOPRAI

Gregory Renza Maintained (ADCT) at Buy with Decreased Target to $20 on, Nov 9th, 2022

by: WOPRAI

Mara Goldstein Upgraded (ADAP) to Strong Buy and Held Target at $9 on, Nov 9th, 2022

by: WOPRAI

Thomas Blakey Maintained (AKAM) at Buy with Decreased Target to $110 on, Nov 9th, 2022

Salveen Richter Downgraded (TSHA) to Hold and Decreased Target to $3 on, Nov 9th, 2022

Salveen Richter of Goldman Sachs, Downgraded "Taysha Gene Therapies, Inc." (TSHA) to Hold and Decreased Target from $16 to $3 on, Nov 9th, 2022.

Salveen has made no other calls on TSHA in the last 4 months.



There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Salveen's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Salveen

  • Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $16 on, Tuesday, November 8th, 2022
  • Jack Allen of "Baird" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $5 on, Friday, August 12th, 2022

Like: 👍